Where to find deep value in investment trusts
Professional investors Nick Greenwood and Charlotte Cuthbertson of the Miton Global Opportunities trust pick three of their favourite investment trusts
The Miton Global Opportunities trust (LSE: MIGO) seeks to find deep value and special situations (unusual stock-specific circumstances that could lead to a rerating) in the investment trust market. In the most basic terms, we look to buy good assets for as little as 70p in the £1. Because the trust can invest in any asset class providing it is available within a closed-ended structure, MIGO’s portfolio enjoys enormous diversification. Below are three interesting opportunities that provide an insight into the wide range of situations that we can exploit.
Thriving after a near-death experience
Private-equity trusts are still languishing on large discounts to net asset value (NAV)following the global market turmoil we saw in March. We believe that investors remain nervous about the level of debt in some of these vehicles and are still haunted by the near-death experience this sector suffered in the Great Financial Crisis of 2008.
Fortunately, the sector does not face the same problems today. Our exposure to private equity is through trusts such as Oakley Capital Investments (LSE: OCI), where we have good visibility regarding the companies it is invested in and the level of gearing employed.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Oakley has invested in many companies that should do well in the post-pandemic environment, such as online learning. The trust currently has plenty of cash, following some profitable sales, and is in a good position to exploit current opportunities.
Access to a famous hedge fund
Third Point Investors (LSE: TPOS) is a feeder fund that invests in the famous US hedge fund Third Point Offshore fund, run by Daniel Loeb. (Feeder funds collect money and then put it in a master fund; this structure is popular with US hedge funds as it tends to be tax-efficient and offers economies of scale.)
Hedge funds are secretive about their investments, but the greater disclosure required in the UK means updates for the London-listed vehicle generate lots of interest on Wall Street as the lid is lifted on what’s going on in the main hedge fund. Should the discount to NAV remain wide then Loeb may tire of the scrutiny and wind it up, generating a useful uplift for shareholders. Hedge fund manager Brevan Howard recently demanded higher fees from its feeder trust and threatened to pull the plug if they are not forthcoming.
UK micro caps remain a bargain
Finally, we have some specialist UK equity exposure in the form of the River and Mercantile UK Micro Cap Trust (LSE: RMMC). We bought into this sector when it was very lowly rated. Since then the trust, which specialises in growth companies in the smallest area of the market, has performed strongly.
We think that the trust should continue to rerate as it is still on a larger discount to NAV than many of its peers. In order to keep the trust manageable in a sector where there is not much liquidity, it routinely hands back cash to shareholders at around NAV in order to cap the size of the portfolio at £100m. The latest redemption will be made at 253p, a useful premium to the price of 218p on the day just before this tender was announced.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Investment trust manager, Nick Greenwood oversees the Premier Miton Worldwide Opportunities Fund. He began his career in private client stock broking and was a founder member of Christows stockbroking operation in 1991. He joined the Christows Investment Trust team setting up their London office in 1995 and became lead manager in November 1997. Nick subsequently joined Premier Miton. The LF Miton Worldwide Opportunities Fund was launched in April 2003 and was followed by the Miton Worldwide Growth Trust in 2004.
-
HMRC confirms crypto ETN ISA status
With crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pension investors targeted by fine wine scams – the tactics to watch for
Wine has emerged as the latest lure in investment fraud, with pensioners being specifically targeted by scammers
-
Pierre-Édouard Stérin wants to make France great again
Conservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with follies
The best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?